TMCnet News
World Niemann Pick C1 Like Protein 1 (NPC1L1) Therapeutics Pipeline Review 2016 - Research and MarketsResearch and Markets has announced the addition of the "Niemann Pick C1 Like Protein 1 (NPC1L1) - Pipeline Review, H1 2016" report to their offering. Niemann Pick C1 Like Protein 1 (NPC1L1) Niemann-Pick C1-Like 1 (NPC1L1) is a gene associated with NPC1 which mutation results in Niemann-Pick disease. It is found on the gastrointestinal tract epithelial cells as well as in hepatocytes. It appears to bind to a critical mediator of cholesterol absorption. Niemann Pick C1 Like Protein 1 (NPC1L1) pipeline Target (News - Alert) constitutes close to 8 molecules. Out of which approximately 8 molecules are developed by Companies. The molecules developed by Companies in Pre-Registration, Phase III, Phase II and Preclinical stages are 2, 3, 2 and 1 respectively. Niemann Pick C1 Like Protein 1 (NPC1L1) - Pipeline Review, H1 2016, outlays comprehensive information on the Niemann Pick C1 Like Protein 1 (NPC1L1) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) nd molecule type. It also reviews key players involved in Niemann Pick C1 Like Protein 1 (NPC1L1) targeted therapeutics development, features dormant and discontinued projects and latest news and press releases. Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/j9j57g/niemann_pick_c1 Related Topics: Infectious Diseases Drugs
View source version on businesswire.com: http://www.businesswire.com/news/home/20160829005872/en/ |